09:53 AM EST - Medicenna Therapeutics Corp. : Announced today the appointment of Brent Meadows, MBA, as its Chief Business Officer, as part of the Company’s plans to establish a world-class C-suite in Boston, the industry’s largest biotech hub. Meadows brings over 25 years of business development, commercial strategy and marketing experience at large pharma and biotech companies, including Johnson & Johnson, Bristol-Myers Squibb, Shire/Baxalta, and Regeneron, among others. Medicenna Therapeutics Corp.
shares T.MDNA are trading up $0.01 at $0.51.
